142 related articles for article (PubMed ID: 17311099)
1. Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects.
Boucard CC; Hoogduin JM; van der Grond J; Cornelissen FW
PLoS One; 2007 Feb; 2(2):e222. PubMed ID: 17311099
[TBL] [Abstract][Full Text] [Related]
2. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects.
Bernabeu A; Alfaro A; García M; Fernández E
Neuroimage; 2009 Oct; 47(4):1172-6. PubMed ID: 19426816
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
5. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.
Wang PY; Kaufmann WE; Koth CW; Denckla MB; Barker PB
Ann Neurol; 2000 Apr; 47(4):477-84. PubMed ID: 10762159
[TBL] [Abstract][Full Text] [Related]
6. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
8. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity.
Lang UE; Hellweg R; Seifert F; Schubert F; Gallinat J
Biol Psychiatry; 2007 Sep; 62(5):530-5. PubMed ID: 17560556
[TBL] [Abstract][Full Text] [Related]
11. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
12. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1.
Dichgans M; Herzog J; Freilinger T; Wilke M; Auer DP
Neurology; 2005 Feb; 64(4):608-13. PubMed ID: 15728280
[TBL] [Abstract][Full Text] [Related]
13. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
[TBL] [Abstract][Full Text] [Related]
14. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.
Brooks WM; Sabet A; Sibbitt WL; Barker PB; van Zijl PC; Duyn JH; Moonen CT
J Rheumatol; 1997 Dec; 24(12):2323-9. PubMed ID: 9415636
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
16. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
17. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
18. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
20. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Chiarini P; Gallai V
J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
